Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAferian Regulatory News (AFRN)

  • This share is currently suspended. It was suspended at a price of 0.55
  • There is currently no data for AFRN

Director/PDMR Shareholding

18 Sep 2023 07:00

RNS Number : 6832M
Aferian PLC
18 September 2023
 

18 September 2023

 

Aferian plc

Directors' Dealings

Aferian plc (LSE:AFRN, "Company" or "AFRN") received notification on the 15 September 2023 from Kestrel Partners LLP ("Kestrel") that on the 15 September 2023 it purchased, on behalf of its discretionary client accounts, an aggregate of 125,000 ordinary shares of 1p each ("Shares") in the Company at an average price of 16.7 pence per share.

Mr Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in AFRN.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Royde is deemed to have a beneficial interest in) 16,784,114 Shares in the Company, and other clients of Kestrel, in which Mr Royde has no beneficial interest hold 12,067,622 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 28,851,736 Shares in the Company, which represents 25.94 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,784,114

15.09%

Indirect

JIM Nominees Limited

756,163

0.68%

Indirect

Bank of New York Nominees Ltd

7,463,390

6.71%

Indirect

Northern Trust Company AVFC

3,848,069

3.46%

 

For further information contact:

 

Aferian Plc

Donald McGarva, Chief Executive Officer

Mark Carlisle, Chief Financial Officer

 +44 (0) 1223 598197

 

 

Investec (NOMAD and Broker)

David Anderson / Patrick Robb / Nick Prowting / Cameron MacRitchie

 

+44 (0) 20 7597 5970

 

FTI Consulting LLP (Financial Communications)

Matt Dixon / Emma Hall / Tom Blundell / Aisha Hamilton

+44 (0) 203 3727 1000

 

 

 

 

 

 

 

 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Max Royde (non-executive director Aferian plc)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Aferian plc

b)

 

LEI

 

21380068JIMBNNZJL315

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1p each 

 

ISIN: GB00B013SN63

 

b)

 

Nature of the transaction

 

 Purchase

c)

 

Price(s) and volume(s)

 

Transfer

 

Purchase

 

Purchase

15 September 2023

Price(s)

 

Volume(s)

16.7 pence

125,000 shares

d)

 

Aggregated information

- Aggregated volume

- Price

 

Purchase Total 125,000 shares at an average price of 16.7 pence.

e)

 

Date of the transaction

 

15 September 2023

f)

 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGMLVNNGFZM
Date   Source Headline
23rd Dec 202511:51 amRNSForm 8.3 [Aferian]
22nd Dec 202510:53 amPRNForm 8.3 - Aferian plc
22nd Dec 202510:12 amRNSForm 8.3 [Aferian]
19th Dec 202510:47 amRNSForm 8.3 Aferian
18th Dec 202511:13 amRNSForm 8.3 - Aferian plc
18th Dec 20257:00 amRNSTrading Update
17th Dec 202510:28 amRNSForm 8.3 - Aferian plc
15th Dec 202510:52 amRNSForm 8.3 Aferian
12th Dec 202511:49 amRNSForm 8.3 - Aferian plc
12th Dec 20257:00 amRNSExtension to Senior Banking Facilities
10th Dec 202512:06 pmRNSForm 8.3 - Aferian plc
8th Dec 20251:53 pmRNSForm 8.3 - Aferian plc
4th Dec 202510:47 amRNSForm 8.3 - Aferian plc
3rd Dec 20252:47 pmRNSForm 8.3 - Aferian plc
1st Dec 202511:52 amRNSForm 8.3 - Aferian plc
28th Nov 20259:48 amRNSExtension to Banking Facilities - General Update
27th Nov 202511:35 amRNSForm 8.3 - Aferian plc
26th Nov 202511:28 amRNSForm 8.3 - [Aferian plc]
25th Nov 202512:12 pmRNSForm 8.3 - Aferian
20th Nov 202511:59 amRNSForm 8.3 - Aferian
19th Nov 20251:46 pmRNSForm 8.3 - Aferian plc
18th Nov 202511:14 amRNSForm 8.3 - Aferian plc
17th Nov 202510:51 amRNSForm 8.3 - Aferian Plc
14th Nov 202512:41 pmRNSForm 8.3 - Aferian Plc
12th Nov 202512:28 pmRNSForm 8.3 - Aferian plc
11th Nov 202511:29 amRNSForm 8.3 - Aferian plc
10th Nov 202511:16 amRNSForm 8.3 - Aferian plc
7th Nov 20252:58 pmRNSForm 8.3 - Aferian plc
6th Nov 202511:40 amRNSForm 8.3 - Aferian plc
3rd Nov 20252:54 pmRNSForm 8.3 Aferian plc
31st Oct 202510:57 amRNSForm 8.3 - [Aferian plc]
30th Oct 202510:53 amRNSForm 8.3 - Aferian plc
29th Oct 202511:25 amRNSForm 8.3 - Aferian plc
28th Oct 20253:33 pmRNSForm 8 (DD) - Aferian plc
28th Oct 202512:26 pmRNSForm 8.3 - Aferian plc
23rd Oct 202510:41 amRNSForm 8.3 - Aferian plc
22nd Oct 202512:23 pmRNSForm 8.3 - Aferian plc
21st Oct 20252:32 pmRNSForm 8.3 - Aferian plc
9th Oct 202512:45 pmRNSForm 8.3 - Aferian plc
9th Oct 20259:39 amRNSForm 8.3 - Aferian plc Amendment
8th Oct 20259:10 amRNSForm 8.3 - [Aferian plc]
6th Oct 20255:46 pmRNSForm 8.3 - Aferian plc Amendment
6th Oct 202510:49 amRNSForm 8.3 - Aferian plc
3rd Oct 20253:15 pmRNSForm 8 (OPD) - Aferian plc
3rd Oct 20253:14 pmRNSForm 8.3 - Aferian plc
3rd Oct 20251:53 pmRNSForm 8.3 - AFERIAN PLC
3rd Oct 20257:00 amRNSForm 8.3 - Aferian plc
2nd Oct 202511:27 amRNSForm 8.3 - [Aferian plc]
2nd Oct 20259:46 amRNSForm 8.3 - Aferian PLC
1st Oct 20251:15 pmRNSForm 8.3 - Aferian plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.